Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Researchers reported that a lung MRI technique that uses inhaled gas can identify early patchy lung defects in patients with ...

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...

Let's help them breathe easy again with natural solutions like PhytoRelief-Plus immunity lozenges, exercise, and a healthy ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Out of the pipelines, tremendous ongoing research is being done to obtain new bronchodilators and anti-inflammatory therapies for COPD ... are already on optimal treatment, when the risk-to ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...